Add like
Add dislike
Add to saved papers

Statement on the revised targeted risk assessment for certain maximum residue levels for nicotine.

EFSA journal 2023 March
In accordance with Article 43 of Regulation (EC) No 396/2005, the Department of Agriculture, Food and the Marine (DAFM) of Ireland requested EFSA to re-evaluate the acute (short-term) risk for European consumers related to nicotine exposure via residues in rose hips (code 0154050), teas ( Camellia sinensis , 0610000) and capers (0850020) at the level equal to the temporary maximum residue level (tMRL) established in Reg. (EU) 2022/1290 and the tMRL recently voted in the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee). The requestor asked EFSA to perform the calculation with a revised version of EFSA PRIMo rev. 3.1, in which the Irish children consumption data for tea should be replaced with consumption data for tea from another EU Member State, since the Irish consumption data implemented in EFSA PRIMo rev. 3.1 were not confirmed by the Food Safety Authority of Ireland. In the present assessment, EFSA confirmed the previously identified potential acute exposure risks for the intake of nicotine through rose hips jam containing residues at the current EU MRL of 0.3 mg/kg. The new tMRL for rose hips of 0.2 mg/kg is unlikely to pose a risk to consumers. For the consumption of tea and capers containing residues at the levels of the current and the recently voted tMRLs, a consumer health risk is unlikely.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app